Search NLS News

In this world of rapidly changing regulatory requirements and hyper-competitive global environment, life science companies need to pursue true digital transformation by leveraging comprehensive solutions to provide intelligence-driven insights at precisely the right moment within the organization’s workflows. Historically, quality operations supporting product lifecycle activities had a significant percentage of time dedicated to inspection, verification […]

NorthX Biologics has appointed Janet Hoogstraate as its new Chief Executive Officer with immediate effect. This move follows the company’s strategic merger with Valneva Sweden’s Clinical Trial Manufacturing Unit announced July 3, 2023. “We are delighted to invite Janet to the helm,” says chairman Thomas Eldered. “Her deep-rooted understanding of the industry and impressive track […]

The Japanese Patent Office (JPO) is granting a new drug substance patent for the antibody BAN0805, invented by BioArctic as a potential treatment of Parkinson’s disease. The patent will expire in 2041, with the possibility of a patent term extension up until 2046. The aim is to develop a treatment that halts or slows the […]

Icelandic deCODE genetics and its collaborators employed artificial intelligence (AI) to develop a protein score to predict major atherosclerotic cardiovascular disease events. In a large retrospective analysis using measurements of thousands of plasma proteins in primary and secondary event populations, scientists from deCODE genetics and collaborators from USA, Denmark, and Iceland, reported in The Journal […]

The 15th patient with advanced hepatocellular carcinoma (HCC) has been included in the company’s ongoing phase 2a study. The study evaluates safety and efficacy with the candidate drug fostrox in combination with Lenvima in patients for whom current first- or second-line treatment has proven ineffective or is not tolerable. Positive results The preliminary results from […]

Episurf Medical has announced that the company’s first commercial case in the US has been scheduled for surgery. This is also the first case ever with the newly introduced product Episealer Patellofemoral System, states the company. The product is a fully individualized implant system for patients with isolated osteoarthritis of the patellofemoral joint in the […]

The Lithuanian life sciences sector is pivotal to the country’s economic growth while addressing global and public health challenges. Representing 3 percent of the nation’s GDP, this sector in Lithuania demonstrates continuous growth, with aspirations to emerge as a premier destination for life sciences within Europe by 2030. It drives job creation and has a […]

The life science science park has initiated CO-AX, a rebranding of its non-profit accelerator for startup and scaleup companies. The decision to rebrand the accelerator activities at Sahlgrenska Science Park as CO-AX reflects the accelerator’s increasingly important role to nurture and support entrepreneurs looking to develop innovative tech solutions that address global health challenges, states […]

Herantis Pharma has announced that the dosing of the healthy volunteers in part 2 of the Phase 1a clinical study has been started based on decision from the Data and Safety Monitoring Board. Top-line data of the Phase 1a clinical study is expected in Q4 2023. Thanks to its multimodal mechanism of action, Herantis’ HER-096 […]

The Group has resolved on non-cash flow affecting one-off items predominantly related to goodwill impairment due to increased WACC for group companies, write-down of assets and revised earn-out estimates. This results in an effect on EBITDA of 94 million SEK and -830 million SEK on EBIT in Q2 2023. Erik Gatenholm steps down The Group […]